restricting the use of Trovan (trovafloxacin)
July 1999
The FDA is restricting the use of Trovan (trovafloxacin)...too many cases of severe liver toxicity.
Since Trovan came out last year, there have been over 100 reports of liver toxicity...including 6 deaths.
Now the FDA recommends Trovan ONLY for patients with potentially life-threatening infections...who begin therapy in hospitals or long-term care facilities.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote